Physician profile
John Kish
NPI 1902832975
$606.62
in general payments reported to CMS, 2019-2025
9 companies · $98.17 in 2025
The $98.17 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.73 · 2021: $147 · 2022: $65.08 · 2023: $251 · 2024: $18.10 · 2025: $98.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $367.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $312.40 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $100.94 | 2019-2024 | Xarelto |
| Pfizer INC. | $78.15 | 2021-2023 | |
| Alexion Pharmaceuticals, INC. | $27.46 | 2023 | Ultomiris |
| Merck Sharp & Dohme LLC | $26.72 | 2021-2023 | Zerbaxa, Dificid, Recarbrio |
| Novartis Pharmaceuticals Corporation | $16.68 | 2022 | |
| Abbvie INC. | $15.93 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $14.84 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.